CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment-Reference-Cited by-同舟云学术

CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment

Published:2013-11 Issue:11 Volume:23 Page:627-630
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Almoguera Berta,Riveiro-Alvarez Rosa,Lopez-Castroman Jorge,Dorado Pedro,Vaquero-Lorenzo Concepción,Fernandez-Piqueras José,LLerena Adrián,Abad-Santos Francisco,Baca-García Enrique,Dal-Ré Rafael,Ayuso Carmen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference7 articles.

1. Pharmacogenetics of clinical response to risperidone.;Llerena;Pharmacogenomics,2013

2. The positive and negative syndrome scale (PANSS) for schizophrenia.;Kay;Schizophr Bull,1987

3. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.;Leucht;Acta Psychiatr Scand Suppl,2009

4. The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.;Gaedigk;Clin Pharmacol Ther,2008

5. The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation.;De Leon;J Clin Psychiatry,2005

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Into a Deeper Understanding of CYP2D6’s Role in Risperidone Monotherapy and the Potential Side Effects in Schizophrenia Spectrum Disorders;International Journal of Molecular Sciences;2024-06-08

2. Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review;International Journal of Molecular Sciences;2023-03-01

3. CYP2D6 pharmacogenetics and phenoconversion in personalized medicine;Expert Opinion on Drug Metabolism & Toxicology;2022-11-02

4. Effects of CYP2D6, CYP3A5, and ABCB1 gene polymorphisms on the pharmacokinetics of two risperidone long-acting injection microsphere formulations;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2021-07

5. Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics;Pharmaceutics;2021-06-23